Clinical Trials Browser

Liposarcoma × zimberelimab × Clear all

NCT05886634 2025-10-20

A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

Phase 2 Active not recruiting

Liposarcoma, Sarcoma